Low dialysate sodium levels for chronic haemodialysis

血液透析 医学 内科学 重症监护医学 材料科学 冶金
作者
Joanna Dunlop,Alain C. Vandal,Mark R. Marshall
出处
期刊:The Cochrane library [Elsevier]
被引量:51
标识
DOI:10.1002/14651858.cd011204.pub2
摘要

Background Cardiovascular (CV) disease is the leading cause of death in dialysis patients, and strongly associated with fluid overload and hypertension. It is plausible that low dialysate [Na+] may decrease total body sodium content, thereby reducing fluid overload and hypertension, and ultimately reducing CV morbidity and mortality. Objectives This review evaluated harms and benefits of using a low (< 138 mM) dialysate [Na+] for maintenance haemodialysis (HD) patients. Search methods We searched the Cochrane Kidney and Transplant Register of Studies up to 7 August 2018 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. Selection criteria Randomised controlled trials (RCTs), both parallel and cross‐over, of low (< 138 mM) versus neutral (138 to 140 mM) or high (> 140 mM) dialysate [Na+] for maintenance HD patients were included. Data collection and analysis Two investigators independently screened studies for inclusion and extracted data. Statistical analyses were performed using random effects models, and results expressed as risk ratios (RR) for dichotomous outcomes, and mean differences (MD) or standardised MD (SMD) for continuous outcomes, with 95% confidence intervals (CI). Confidence in the evidence was assessed using GRADE. Main results We included 12 studies randomising 310 patients, with data available for 266 patients after dropout. All but one study evaluated a fixed concentration of low dialysate [Na+], and one profiled dialysate [Na+]. Three studies were parallel group, and the remaining nine cross‐over. Of the latter, only two used a washout between intervention and control periods. Most studies were short‐term with a median (interquartile range) follow‐up of 3 (3, 8.5) weeks. Two were of a single HD session, and two of a single week's HD. Half of the studies were conducted prior to 2000, and five reported use of obsolete HD practices. Risks of bias in the included studies were often high or unclear, lowering confidence in the results. Compared to neutral or high dialysate [Na+], low dialysate [Na+] had the following effects on "efficacy" endpoints: reduced interdialytic weight gain (10 studies: MD ‐0.35 kg, 95% CI ‐0.18 to ‐0.51; high certainty evidence); probably reduced predialysis mean arterial blood pressure (BP) (4 studies: MD ‐3.58 mmHg, 95% CI ‐5.46 to ‐1.69; moderate certainty evidence); probably reduced postdialysis mean arterial BP (MAP) (4 studies: MD ‐3.26 mmHg, 95% CI ‐1.70 to ‐4.82; moderate certainty evidence); probably reduced predialysis serum [Na+] (7 studies: MD ‐1.69 mM, 95% CI ‐2.36 to ‐1.02; moderate certainty evidence); may have reduced antihypertensive medication (2 studies: SMD ‐0.67 SD, 95% CI ‐1.07 to ‐0.28; low certainty evidence). Compared to neutral or high dialysate [Na+], low dialysate [Na+] had the following effects on "safety" endpoints: probably increased intradialytic hypotension events (9 studies: RR 1.56, 95% 1.17 to 2.07; moderate certainty evidence); probably increased intradialytic cramps (6 studies: RR 1.77, 95% 1.15 to 2.73; moderate certainty evidence). Compared to neutral or high dialysate [Na+], low dialysate [Na+] may make little or no difference to: intradialytic BP (2 studies: MD for systolic BP ‐3.99 mmHg, 95% CI ‐17.96 to 9.99; diastolic BP 1.33 mmHg, 95% CI ‐6.29 to 8.95; low certainty evidence); interdialytic BP (2 studies:, MD for systolic BP 0.17 mmHg, 95% CI ‐5.42 to 5.08; diastolic BP ‐2.00 mmHg, 95% CI ‐4.84 to 0.84; low certainty evidence); dietary salt intake (2 studies: MD ‐0.21g/d, 95% CI ‐0.48 to 0.06; low certainty evidence). Due to very low quality of evidence, it is uncertain whether low dialysate [Na+] changed extracellular fluid status, venous tone, arterial vascular resistance, left ventricular mass or volumes, thirst or fatigue. Studies did not examine cardiovascular or all‐cause mortality, cardiovascular events, or hospitalisation. Authors' conclusions It is likely that low dialysate [Na+] reduces intradialytic weight gain and BP, which are effects directionally associated with improved outcomes. However, the intervention probably also increases intradialytic hypotension and reduces serum [Na+], effects that are associated with increased mortality risk. The effect of the intervention on overall patient health and well‐being is unknown. Further evidence is needed in the form of longer‐term studies in contemporary settings, evaluating end‐organ effects in small‐scale mechanistic studies using optimal methods, and clinical outcomes in large‐scale multicentre RCTs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
JIE发布了新的文献求助10
刚刚
刚刚
遮宁完成签到,获得积分10
刚刚
doctoranran发布了新的文献求助30
刚刚
林岚完成签到,获得积分10
1秒前
34882738完成签到 ,获得积分10
1秒前
1秒前
曲小晴完成签到,获得积分10
1秒前
luria完成签到,获得积分10
2秒前
SherlockHe发布了新的文献求助10
2秒前
田园完成签到,获得积分10
3秒前
fireking_sid发布了新的文献求助10
3秒前
zhangruiii完成签到 ,获得积分10
3秒前
田田完成签到,获得积分10
3秒前
3秒前
Nemo1234完成签到,获得积分10
4秒前
包容友儿完成签到,获得积分10
5秒前
5秒前
荡乎宇宙如虚舟完成签到,获得积分10
5秒前
6秒前
7秒前
顺顺利利完成签到,获得积分10
7秒前
7秒前
7秒前
7秒前
海人完成签到 ,获得积分10
8秒前
fireking_sid完成签到,获得积分10
8秒前
科研通AI5应助hhh采纳,获得10
9秒前
11发布了新的文献求助10
9秒前
10秒前
俗丨发布了新的文献求助10
10秒前
Murphy完成签到 ,获得积分10
11秒前
大胆胡萝卜完成签到,获得积分10
11秒前
细腻的歌曲完成签到,获得积分10
12秒前
12秒前
aam完成签到,获得积分10
12秒前
超级无敌奥特大王完成签到,获得积分10
12秒前
XJY完成签到,获得积分10
12秒前
高分求助中
Nickel, Cobalt and Palladium Catalysed Infarction with Ventricular following rich structural diversity 1000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968608
求助须知:如何正确求助?哪些是违规求助? 3513486
关于积分的说明 11168243
捐赠科研通 3248926
什么是DOI,文献DOI怎么找? 1794540
邀请新用户注册赠送积分活动 875188
科研通“疑难数据库(出版商)”最低求助积分说明 804676